scispace - formally typeset
E

Edward J. Pearce

Researcher at Max Planck Society

Publications -  237
Citations -  34759

Edward J. Pearce is an academic researcher from Max Planck Society. The author has contributed to research in topics: Schistosoma mansoni & Immune system. The author has an hindex of 81, co-authored 218 publications receiving 30184 citations. Previous affiliations of Edward J. Pearce include National Institutes of Health & Ithaca College.

Papers
More filters
Journal ArticleDOI

Schistosoma mansoni: The cutaneous response to cercarial challenge in naive guinea pigs and guinea pigs vaccinated with highly irradiated cercariae

TL;DR: It is concluded that a percentage of the challenge larvae, however small, is preferentially killed in the skin of the vaccinated animals.
Journal ArticleDOI

Kinetic correlation of the acquisition of resistance to immune attack in schistosomula of Schistosoma mansoni with a developmental change in membrane potential.

TL;DR: In this study, in vivo or in vitro schistosomula of different ages were examined for developmentally linked changes in membrane function which might correlate with the attainment of the resistant state.
Journal ArticleDOI

The cell identity of cytotoxic T lymphocytes.

TL;DR: Proteomic profiling of cytotoxic T cells brings them into unprecedented and revealing focus as a major focus of immunology research for decades.
Journal ArticleDOI

CD4+ T-cell receptor V beta usage during the immune response to Schistosoma mansoni.

TL;DR: T-cell receptor V beta usage by CD4+ cells during the immune response of C57BL/6J mice to Schistosoma mansoni was examined and preferential V Beta usage or deletion was not detected when either the primary or the memory immune response to parasite eggs was examined.
Journal ArticleDOI

MZB1 enables efficient interferon α secretion in stimulated plasmacytoid dendritic cells.

TL;DR: This paper showed that MZB1 is also expressed in plasmacytoid dendritic cells (pDCs) and showed that pDCs have a defect in the secretion of interferon (IFN) α upon TLR 9 stimulation and a reduced ability to enhance B cell differentiation towards plasma cells.